Skip to main content
Premium Trial:

Request an Annual Quote

Kevin King, John Taylor

Premium
Affymetrix has promoted Kevin King to president of the company from his previous post as vice president of life sciences and executive vice president. King joined Affy in January of this year. Prior to that, he was CEO and president of Thomson Healthcare and also held executive-level roles at GE Healthcare and Hewlett-Packard.
 

 
John Taylor has been tapped to take the role of executive vice president of health with the Biotechnology Industry Organization. Taylor was an executive at Abbott, and held senior-level positions for 14 years at the US Food and Drug Administration.

Filed under

The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.